Search 1
Entities
LogoName Σ Employees
MDoloris Medical Systems MDoloris Medical Systems

Our technology help clinicians titrating analgesics to control surgical stress, and improve outcomes in both OR and ICU MDoloris Medical Systems is a young innovative start-up (ISO 9001 and ISO 13485 certified) created in June 2010 to leverage more than 23 years of academic research conducted at the University Hospital of Lille. Our mission is to provide clinicians with the means to efficiently, continuously and non-invasively asses patient pain and comfort. The goal is to personalize pain therapy, in order to avoid known adverse effects of over- or underdosage of those drugs. Our technology is ideal when patients are unable …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

3 2 0 36
OncoDNA OncoDNA

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 2 4 111
Stilla Technologies Stilla Technologies

Discover the Sensitivity & Simplicity of Multiplex Crystal Digital PCRTM Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCRTM technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world's first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 2 4 107
Allogene Therapeutics Allogene Therapeutics

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

5 2 3 281
Magenta Therapeutics Magenta Therapeutics

Developing novel medicines to bring the curative power of stem cell transplants to more patients Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients. Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com. Follow Magenta on Twitter: @magentatx. Hematopoietic Stem Cell …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 2 1 61
Drepacare Drepacare

[Automatic translation follows] Drepacare is the first mobile application intended for #sickle cell patients. Sickle cell anemia is the most widespread genetic disease in the world, 50 million people are affected, including 12,000 in France. Created in 2016 by three entrepreneurs/students in a Master's degree in nutrition and public health in parallel with their careers as pharmacists, nurses and engineers in biotechnology, it aims to make the daily lives of patients easier with functionalities that help manage treatments, diet, frequency of attacks, hospitalizations. The idea starting from the observation of a great lack of communication and information on sickle cell …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

8 2 4 5
Neuron Guard Neuron Guard

THE NEW STANDARD OF CARE FOR THE TARGETED TEMPERATURE MANAGEMENT OF PATIENTS Neuron Guard is an Italian medical device company that has developed a technology to deliver hot and cold therapy for body surfaces. One application is for selective brain temperature management. Other treatment options are focused on the need for local cooling or heating of body surfaces. The company was formally founded in 2013 for the development of portable non invasive cooling and warming systems. Our product CB240_Aurora is a portable hot or cold therapy system composed by a collar/wrap powered by a smart control unit. In 2022 CB240_Aurora …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

4 2 1 3
The Medicine Maker The Medicine Maker

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

17 2 15 3
Benhur Benhur

[Automatic translation follows] "The best ally for your company" We help you through digital marketing to reach another level!

Type: SMB Activities: martech Technologies: Synthetic Biology

2 2 0 180
Coave Therapeutics Coave Therapeutics

Coave therapeutics new brand for Horama Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

4 2 1 39
Recursion Recursion

Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

11 2 9 572
Medica Media Medica Media

Medica Media provides print, web-based and mobile media solutions for medical professionals. Written by doctors for doctors. Makers of PocketDr. PocketDr is the must-have app for all junior doctors with on-call responsibilities. It is an aide-memoire for the things you know - but may not recall quickly in the dead of night with constant bleeps and distractions. Succinct. Pre-digested info. When you need it. Contents include: - Checklists for assessment of the deteriorating patient. Be prepared for any NEWS call: Hypoxia, Tachycardia, Hypotension, low GCS. - Checklists for management of 21 acute medical conditions including: ACS, AF, Asthma, Delerium, Hyperkalaemia, …

Type: Startup Activities: healthtech IT Services Technologies: Synthetic Biology

10 2 9 1
Leuko Leuko

Non-invasive white cell monitoring Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device. Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

3 2 1 15
DIA DIA

Empower healthcare innovation with DIA Experience the power of collaborative innovation with DIA (Drug Information Association)!Since 1964, our passionate, volunteer-based global network works together to provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments. Join our dynamic, nonprofit organization that serves as a hub for life sciences professionals, academia, advocates, and policymakers worldwide. At DIA, we foster interdisciplinary connections, engaging patients, peers, and visionary leaders in tackling today's challenges and shaping tomorrow's breakthroughs. Unleash your potential with our knowledge resources, …

Type: SMB Activities: healthtech deeptech biotech edtech govtech Technologies: Synthetic Biology

11 2 8 461
Excelya Excelya

Expertly delivering clinical trials operations, with care. Excelya is an independent partner that serves Biotech, Pharma, and Medical Device organizations with a comprehensive range of Full-service CRO, FSP, and Resourcing solutions guided by compassion, care, and excellence. Founded in 2014 and headquartered in Paris, France, and operating in 28 countries across Europe, USA and India, Excelya has a global team of 900+ experts who understand the critical needs of clients to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas, with speciality focus on Oncology & Hematology, Rare Disease & Pediatrics, Infectious Disease, Inflammation & Immunotherapy, …

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 2 3 702
Cellforcure Cellforcure

a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an …

Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology

2 2 0 104
Fraunhofer Institute for Interfacial Engineering and Biotechnology Fraunhofer Institute for Interfacial Engineering and Biotechnology

We combine biology and engineering The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research …

Type: SMB Activities: deeptech biotech Technologies: New Materials Synthetic Biology

5 2 2 220
LUMICKS LUMICKS

Empowering scientists with tools that reveal crucial insights not available before, at the molecular and cellular level. LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 2 2 182
CN Bio CN Bio

Generate human-specific efficacy and safety data with PhysioMimix® Single- and Multi-organ microphysiological systems. CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 2 4 47
Bicycle Therapeutics Bicycle Therapeutics

Bicycle Precision Guided Therapeutics. Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTCTM) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICATM targeting Nectin-4 and agonizing CD137, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

6 2 1 272
The Task Force for Global Health, Inc. The Task Force for Global Health, Inc.

We take on BIG problems. We have REAL impact. The Task Force for Global Health is an international, nonprofit organization that works to improve health of people most in need, primarily in developing countries. Founded in 1984 by global health pioneer Dr. Bill Foege, The Task Force consists of programs focused on neglected tropical diseases, vaccines, field epidemiology, public health informatics, and health workforce development. The Task Force works in partnership with ministries of health and hundreds of organizations, including major pharmaceutical companies that donate billions of dollars annually in essential medicines. Major funders include the Bill & Melinda Gates …

Type: SMB Activities: healthtech transporttech Technologies: Synthetic Biology

11 2 10 239
C4 Therapeutics, Inc. C4 Therapeutics, Inc.

Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 2 3 124
Exscientia Exscientia

Better drugs, faster Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a …

Type: Startup Activities: biotech deeptech manufacturing Technologies: A.I. Synthetic Biology

7 2 5 474
Sage Therapeutics Sage Therapeutics

Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

8 2 4 611
Crescendo Biologics Limited Crescendo Biologics Limited

Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 2 3 62
Vibiosphen Vibiosphen

From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

4 2 2 8
Green Chimneys Green Chimneys

Green Chimneys is a multi-faceted nonprofit helping young people to maximize their full potential by providing education, residential, clinical and recreational services in a safe and supportive environment that nurtures connections with their families, the community, animals, and nature. special education, social services, animal assisted therapy, animal assisted activities, therapeutic school, farm, wildlife rehabilitation, nature-based education, social work, animal assisted activities, animal assisted interventions, human animal interventions, and residential treatment

Type: SMB Activities: edtech Technologies: Synthetic Biology

3 2 1 375
STARRY STARRY

STARRY's diverse staff nurtures children, strengthens families, & restores hope through free child and family services. STARRY's diverse staff nurtures children, strengthens families, and restores hope through no-cost family counseling, fatherhood, and family preservation services. STARRY offers free community counseling across 30+ Texas counties, guided by professionalism, grace, and love. We provide an array of dynamic free fatherhood services in McLennan and Bell Counties. STARRY's Family Preservation provides therapeutic support to foster children, foster families, and biological families through family engagement services and case management services. Counseling, Fatherhood, Family Resource Center, and Family Wellbeing

Type: SMB Activities: kidtech healthtech Technologies: Synthetic Biology

12 2 7 94
Repositive Repositive

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners Repositive is committed to accelerating the development of precision cancer therapies to the clinic by working with biopharmas and Contract Research Organisations (CROs) to improve the predictivity of pre-clinical cancer research. Through its Cancer Models Scout service, Repositive is helping biopharmas to optimise their pre-clinical cancer projects by identifying the most suitable cancer models for their requirements from its world-leading database of over 8000 models, as well as via outreach to an extended network of CRO contacts. Repositive works to connect researchers with the right …

Type: Startup Activities: biotech deeptech IT Services Technologies: Synthetic Biology

5 2 3 2
TB TB

TB is an internet company.

Type: Startup Activities: healthtech Technologies: Synthetic Biology

6 2 1 866
Cyclica (acquired by Recursion, Nasdaq: RXRX) Cyclica (acquired by Recursion, Nasdaq: RXRX)

From molecule to medicine Unlocking the protein universe to discover the medicines of tomorrow Cyclica has been acquired by Recursion! Please follow @Recursion on LinkedIn and @RecursionPharma on Twitter to receive updates on our next chapter. Drug Development, Network Pharmacology, Drug Repositioning, Proteomics, Clinical Trials, Side Effects, Bioinformatics, Systems Biology, Drug Discovery, Artificial Intelligence, polypharmacology, medicines, Machine learning, pharmacology, pharmaceuticals, and bioinformatics

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. A.I. - Machine Learning

15 2 11 8
Molsid Molsid

Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 2 5 14
Shockwave Medical Shockwave Medical

Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

2 2 1 1,172
BIOGARAN BIOGARAN

[Automatic translation follows] The box that takes care of you. French drug laboratory 🇫🇷 Biogaran was founded in 1996, to specifically respond to the development of a new, still little-known market: generic medicines. Offering patients quality medicines with recognized effectiveness whose patent has fallen into the public domain then required a new type of know-how that traditional laboratories did not possess. Our know-how is available through different ranges: from minor everyday ailments with the Biogaran Conseil® range, to more serious pathologies with prescription medications. Whatever the pathology, patient health is at the heart of Biogaran's concerns and the same rigor …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 2 4 511
Corniche Hospital Corniche Hospital

Maternity hospital in Abu Dhabi Mother-baby friendly hospital Corniche Hospital has a legacy as the most-trusted and leading referral center for Women and Newborn care in Abu Dhabi, with more than 46 years of dedication to motherhood and over 300,000 babies delivered till date. Envisioned by H.H. Sheikha Fatima bint Mubarak, Corniche Hospital offers a comprehensive range of advanced obstetrics, gynecology, and neonatology services, with subspecialty care services and clinics dealing with fetal medicine, infertility, obstetric medicine, aesthetic gynecology, pain management and allied health disciplines, including lactation and physiotherapy. Corniche Hospital has a US accreditation as Centre of Excellence for …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

2 2 0 519
genOway genOway

Together, we science better Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 2 1 109
Luxia Scientific Luxia Scientific

New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, …

Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology

3 2 0 2
Quantum Genomics Quantum Genomics

The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 2 1 7
Biopredic International Biopredic International

Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

3 2 1 27
SYNCROSOME - Preclinical Efficacy CRO SYNCROSOME - Preclinical Efficacy CRO

IN-DEPTH EFFICACY CHARACTERIZATION CRO Syncrosome is a preclinical CRO dedicated to in vivo efficacy studies. More than 60% of new drugs fail in phase 2, we have chosen to focus our activities since 2000 on preclinical in vivo efficacy studies to offer better predictability and anticipate clinical results. Syncrosome offer relevant disease models, cutting-edge techniques, specific biomarkers and a comprehensive background of physiopathology to assist drug discovery companies in selecting their compounds. We have developed and validated so far more than 15 disease models, and our flexible and human-sized organization can design and operate tailored experimental protocols to give you …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 2 1 9
Flash BioSolutions Flash BioSolutions

CDMO expert specialized in gene delivery Flash BioSolutions is a World-class CDMO expert in lentiviral vector manufacturing : With our continuum from research to the clinic we support you throughout your projects from R&D to GMP grade. We provide purified and highly concentrated particles from small scale to large scale with the same vector specifications. Flash BioSolutions provides integrative lentiviral vectors and RNA particles. Lentiviral vectors - LentiCare® : Conventional lentiviral vectors, which lead to DNA integrated into the genome, are a leading delivery method for applications which require a stable and long-term gene expression. Ideal for Gene Therapy and …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

19 2 5 52
PEPTINOV PEPTINOV

Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 2 0 16
Sisu Global Sisu Global

Designing & commercializing medical devices for all healthcare ecosystems. Sisu Global develops patented, cutting-edge, world-class medical devices that are designed to save lives, enable patient access to care and increase resources for healthcare ecosystems. Our medical device, Hemafuse, is a highly effective, mechanical alternative to donor blood and available in Ghana, Kenya, India, and Tanzania. Hemafuse increases access to blood by enabling clinicians to capture a patient’s blood, filter it, and return fresh, whole blood back to that same patient. Hemafuse provides immediate access to blood transfusion across trauma, obstetric, general, and orthopedic surgeries with internal bleeding. We have raised …

Type: Startup Activities: deeptech healthtech civictech Technologies: Synthetic Biology

6 2 5 11
Mymee Mymee

Mymee identifies unique dietary and environmental factors that can worsen autoimmune disease & COVID long haul symptoms. Mymee is the first personalized trial & care platform that helps patients gain control of unpredictable flares associated with autoimmune disease and long COVID. Autoimmune Disease, N of 1, Chronic Disease, Precision Medicine, Digital therapeutics, Population Health, Digital Care, Digital Health, Autoimmunity, Personalized Trials, Women's Health, and Long COVID

Type: Startup Activities: healthtech Technologies: Synthetic Biology

2 2 0 19
GestSure GestSure

The GestSure System allows surgeons to control operating room computers while scrubbed using simple hand gestures. GestSure Technologies is creating rich, touchless gestural interfaces that allow surgeons and interventional radiologists to control the equipment around them. Our system works as a layer on top of existing PACS, 3D visualization, or electronic medical records. That means no clumsy software to install and no need to import imaging into a parallel system. Gestural Interfaces, Medical Devices, and Health IT

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

3 2 2 1
Peptone Peptone

Bringing order to disorder We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

Type: Startup Activities: biotech deeptech IT Services Technologies: Synthetic Biology

31 2 32 47
ALSACHIM SAS ALSACHIM SAS

Label your life Created in 2005, Alsachim is one of the world leaders in the synthesis of stable labeled (13C, 2H, 15N) internal standards, used in Bioanalysis studies, chemicals, building blocks and metabolites. Based on its expertise, Alsachim develops also Therapeutic Drug Monitoring devices to support hospitals and bioanalyse center to their daily work and routine operation. We supply our products to customers all over the world, spread across the chemical discipline including the pharmaceutical and biotech industry, clinical and bio-analytical CROs, and research institutions, in areas such as Health, Food and Environment. Alsachim is a Shimadzu group company, a …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

2 2 0 50
Pharmanity Pharmanity

[Automatic translation follows] PHARMAnity, your local pharmacies 💻 Pharmanity.com allows patients to easily access information about nearby pharmacies listed free of charge on the search engine: contact details, opening hours, products available and prices, services offered and areas of specialization. 👉 Pharmacies can register for free and reference their practical information and all their health-related activities (referencing their medications, areas of specialization and services (screenings, pharmaceutical interviews). Internet, Pharmacies, Health, and Search Engine

Type: Startup Activities: healthtech Technologies: Synthetic Biology

2 2 0 3
g.tec medical engineering GmbH g.tec medical engineering GmbH

Brain-Computer Interfaces & Neurotechnology g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery …

Type: SMB Activities: healthtech biotech deeptech manufacturing Technologies: Affective Computing Synthetic Biology

2 2 1 72
Arterra Bioscience S.p.A. Arterra Bioscience S.p.A.

We care about everybody's health Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers. Biotechnology, R&D, Cosmetics, medical Device, Agriculture, and Agrifood

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 2 0 38
Anuva Anuva

Creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery Anuva is creating the world’s most diverse Genomic Bio/Data Bank to help uncover novel biological pathways for drug discovery. Anuva is a translational research company that is creating the most diverse Genomic Bio/Data Bank of Asian Populations, which is being utilized for research & development within the pharma industry. Our cohorts and biorepository allow for follow-on clinical and translational studies, which greatly empower drug development opportunities. IndiaCHIP, Genomics, Genomics - Emerging markets, Genomics - R&D, Genomics Data Platform, Genomics - India, bioinformatics, and …

Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology

5 2 4 60
Perfect Day Perfect Day

Complete whey protein, made more sustainably. We’re rethinking everything. Starting with food. Using safe, proven fermentation methods we make animal-free whey protein from microflora – not cows – to make dairy that’s identical to traditional milk. The production of our whey protein emits up to 97% less greenhouse gas emissions, uses up to 99% less blue water, and uses up to 60% less nonrenewable energy, compared to the production of protein found in traditional milk. Our protein comes in a variety of applications including cream cheese, barista milk, ice cream, protein powder, egg replacer, bakery mix, confectionery, and gelato. Some …

Type: Startup Activities: agritech biotech deeptech foodtech Technologies: Synthetic Biology

21 2 18 325
Genoscience Pharma Genoscience Pharma

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

6 2 4 7
CapEval Pharma CapEval Pharma

CapEval Pharma, founded in 2010, provides pharmaceutical consultancy services from early pre-clinical to clinical development, specifically in the sectors of Safety, Toxicology, Pharmacology, Ophthalmology, ADME/PK, analytical development, QA, CMC-Regulatory Affairs and Compliance. In addition, CapEval provides expert assessment for due diligence, veterinary drugs, cosmetics, agrochemicals and chemicals as well as staff training. Drawing on > 60 years of combined international experience, we are a team of highly qualified pharmaceutical consultants, fluent in 5 languages. We provide scientific advice and training to identify the best approach to move your projects quickly through development and onto the commercial market. With experience working …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 2 0 2
RD-BIOTECH RD-BIOTECH

Biomanufacturing, development & analytical services: Plasmids, Antibodies, Recombinant proteins, Cells - FastELISA kits French CRO Biotechnology 🔎 BIOMANUFACTURING: Plasmids (R&D and High Quality grades, And Now a pDNA GMP unit), Monoclonal antibodies, Recombinant antibodies (scFV, Fab, bispecific...), recombinant proteins (E.Coli, Cell free system, Yeast and mammalian cells), cells. 💡 Antibody engineering & molecular biology platforms: Antibody sequencing, vector design & cloning, Recombinant antibody production, Chimerization and Humanization, cell line development... ✍ Analytical services: immunoassays development, antibody characterisation, quality controls (R&D and high quality grades) FastELISA kits: Immunoglobulin quantification (human, mouse, rat, bovine), Mouse Immunoglobulin isotyping, Contaminant detection (Protein A), other …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 2 0 50
Tebubio Tebubio

Facilitators of Life Sciences Research Our vision of helping to advance Life Sciences research every day, is embodied by providing a unique, holistic range of solutions to make your life easier – simply and quickly accessible. The full scope of your needs is at the center of our attention. Our experts provide reliable, multimodal solutions, encompassing our extensive range of products, in-house laboratory platforms, and our practical administrative and logistics services. You’ll find the right combination of answers to accelerate your daily work – in one place. Every day, you’ll benefit from our distinctive solutions, from simplified ordering with personalized …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

13 2 12 82
COVALAB COVALAB

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

5 2 3 23
Axoltis Pharma Axoltis Pharma

The CNS Regeneration Company Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders. neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson, and Multiple Sclerosis

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 2 1 12
ANS Biotech ANS Biotech

Our Services are as Unique as Your Discoveries ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with: • Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in the field of inflammatory pain, neuropathic pain and visceral pain ; • Customized scientific studies meeting drug discovery and development objectives ; • Consulting activities. ANS Biotech also offers ALGOGramTM, a unique in vivo screening tool that provides a rapid and cost-effective means to systematically explore pain indications …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

2 2 0 23
Bcell Design Bcell Design

Best-in-class monoclonal antibodies with Human Fc Based in Illkirch-Graffenstaden (France), Bcell Design is a monoclonal design expert. The company has developed unique technologies to produce human Fc monoclonal antibodies with excellent reactivity. 1/ IVD Our high-quality monoclonal antibodies are specifically designed for in vitro diagnostics. They are used for positive controls, calibrators and quality controls. Some products have been tested and found reactive in DiaSorin LIAISON XL assays, BioMérieux Vidas, bioVendor KleeYa system etc... Our products are included in manual and automatic kits, under IVDR and FDA regulations. They are used as a quality control tool for all types of …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

3 2 3 6
STANIPHARM STANIPHARM

Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 2 0 12
Clean Cells Clean Cells

Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, …

Type: SMB Activities: biotech Technologies: Synthetic Biology

7 2 7 122
PhinC Development PhinC Development

15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 2 5 15
UseConcept UseConcept

[Automatic translation follows] Take care of the ergonomics of health products! Specialists in the Aptitude for the Use of Medical Devices. We help you design a product that is relevant, intuitive, safe and pleasant to use. UseConcept supports you in taking care of ergonomics in the design and improvement phases of your products and services. Specializing in user innovations, we have particular expertise in medical IT, medical devices as well as new technologies linked to commerce. We help you better understand the needs of your users and design a product that is complete, intuitive, secure and pleasant to use. These …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

3 2 2 11
Kuur Therapeutics Kuur Therapeutics

Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, and lifesciences

Type: SMB Activities: biotech deeptech transporttech Technologies: Synthetic Biology

2 2 0 99
CTIBiotech CTIBiotech

Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come …

Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

14 2 11 20
Mi Terro® Mi Terro®

Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, …

Type: Startup Activities: agritech biotech cleantech deeptech greentech Technologies: Bio sourced materials New Materials Synthetic Biology

10 2 6 11
The EVERY Company The EVERY Company

Accelerating The World’s Transition To Animal-Free Protein. 🥚🚀 The EVERY Company combines industry-leading expertise in food technology and flavor to enable the foods of tomorrow, today, for the world’s global food and beverage industries. We’re creating game-changing solutions for businesses and brands, with our people and products delivering leveled-up performance, unprecedented outcomes in taste and texture, and animal-free innovation to a host of categories, in line with consumer trends. Along the way, we’re co-creating a better tomorrow, commercializing nutritious, nature-equivalent animal proteins from fermentation that taste and function like the originals, while using significantly less land, water and greenhouse gas …

Type: Startup Activities: agritech healthtech Technologies: Synthetic Biology

12 2 8 98
REGEnLIFE REGEnLIFE

Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, …

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

13 2 11 12
Mission Therapeutics Mission Therapeutics

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 2 5 37
Evox Therapeutics Ltd Evox Therapeutics Ltd

Naturally inspired. Engineered to deliver Evox Therapeutics is harnessing and engineering the natural trafficking capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics. By combining groundbreaking exosome technology from well-renowned Oxford University and the Karolinska Institutet – the home of the Nobel Prize – we aim to revolutionise the treatment of a broad range of severe disease, with profound implications for human health. Based in Oxford, UK, Evox Therapeutics was founded in 2016 by Professor Matthew Wood of Oxford University, Assistant Professor Samir EL Andaloussi and Dr Per Lundin of the Karolinska Institutet, to capitalise on foundational …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 2 0 81
Eat Just, Inc. Eat Just, Inc.

Our mission is to build a food system where everyone eats well. Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company’s expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created America’s fastest-growing egg brand, which is made entirely of plants, and the world’s first-to-market meat made from animal cells instead of slaughtered livestock. food science, food, science, culinary, food production, vegan, vegetarian, cultured meat, …

Type: Startup Activities: foodtech healthtech Technologies: Synthetic Biology

3 2 1 275
AdalbaPro by Ÿnsect AdalbaPro by Ÿnsect

smart insect nutrition Ynsect's high-tech vertical farm and processing facility in the Netherlands produces innovative and sustainable ingredients for the food industry derived from insects under the brand name AdalbaPro. Our functional ingredients contain highly digestible proteins along with essential nutritional building blocks like vitamins, minerals, fiber and healthy fats. In our controlled and highly scalable vertical farm, Ynsect reduces your global footprint in the most effective way. High quality protein powder, Edible oils, Sustainable food ingredients, sustainable food, sustainable feed, and protein manufacturing

Type: Startup Activities: agritech foodtech manufacturing Technologies: Synthetic Biology

4 2 1 9
Air Liquide Medical Systems Air Liquide Medical Systems

Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

5 2 3 383
Orano Med Orano Med

Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 2 6 131
BioIntrant BioIntrant

[Automatic translation follows] Probiotic Agriculture: improving agricultural productivity through plant health BioIntrant integrates more than thirty years of research at the interface of agronomy, pedology, microbial ecology and bioinformatics, in order to develop biostimulants for modern and responsible agriculture. To do this, BioIntrant integrates the plant into its environment (plant triptych, soil structure, microorganisms) to promote its intrinsic capacity to defend itself. It is today possible, thanks to the most advanced technologies and knowledge of the microbial ecology of plants, to restore this natural balance. Biotechnology, Agriculture, Agronomy, Microbiology, Biostimulant, Bioinformatics, and Genomics

Type: Startup Activities: agritech biotech deeptech Technologies: Synthetic Biology

10 2 9 4
Hybrigenics Services Hybrigenics Services

Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins'​ functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

5 2 3 33
Planktovie Planktovie

Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 2 5 4
OptimHal-ProtecSom OptimHal-ProtecSom

Inspired by your breath® 💡 French designer of medical devices in the fields of asthma and allergy 📍 Normandy, France 🎓 Company certified ISO 13485:2016, medical device standard The Laboratory OptimHal-ProtecSom is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy. The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership: - Partnerships for the distribution of its devices, currently available in 30 countries through a network of 15 exclusive partners. - Partnerships …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

4 2 1 28
AdhexPharma AdhexPharma

We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

3 2 3 115
Biotherm Biotherm

Biotherm is a medical devices company based out of 2163 Glendale Galleria, Glendale, California, United States.

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

5 2 1 77
Yuri Yuri

Space biotech for a better life 🧫🚀 yuri is a space biotech company that uses the microgravity environment of space to develop and manufacture superior biotech products. The team of 30+ space engineers and biologists has worked on 20+ payloads for the International Space Station in collaboration with organizations like NASA, ESA, GSK, Charité Berlin. We develop modular bioreactors and incubators for cell cultures, protein crystals or plants and launch them for scientists around the world to the ISS and other spacecraft such as Sierra Nevada Dream Chaser or SpaceX Dragon. We also sell and rent devices to simulate microgravity …

Type: Startup Activities: manufacturing spacetech Technologies: Synthetic Biology

17 2 16 43
Inspirna, Inc. Inspirna, Inc.

Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 0 33
RefleXion Medical RefleXion Medical

SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering

Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

2 2 1 240
Calliditas Therapeutics Calliditas Therapeutics

Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

5 2 0 228
Onalabs Inno-Hub Onalabs Inno-Hub

The future of biomonitoring Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

9 2 7 25
Shorla Oncology Shorla Oncology

At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

4 2 1 27
MOWOOT MOWOOT

Novel non-invasive, non-drug solution to chronic constipation MOWOOT is a growth stage medical device company targeting INTESTINAL TRANSIT DISORDERS with a novel, purely physical, NON-DRUG & NON-INVASVIVE SOLUTION. MOWOOT (legal name USMIMA SL) emerged out of the prestigious, Stanford Biodesign inspired ,program dHEALTH BCN and was founded in 2014. The Intermittent Colonic Exoperistalsis (ICE) treatment and the MOWOOT device have been developed in collaboration with one of Europes leading neuro-rehabilitation hospitals, Institut Guttmann (Barcelona), is IP protected and clinically proven. The medical device MOWOOT is a novel, purely physical, non-drug and non-invasive solution to treat intestinal transit disorders such as: …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

5 2 3 6
Arzeda Arzeda

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

6 2 6 65
Barinthus Biotherapeutics Barinthus Biotherapeutics

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

8 2 4 136
Koniku Koniku

Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw"​ biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are …

Type: Startup Activities: biotech deeptech Technologies: Affective Computing New Materials Synthetic Biology

7 2 5 5
Sesame Sesame

Pay half. Be whole. Sesame is building a radically new healthcare system for uninsured Americans and those with high-deductible plans. The company's marketplace replaces historically inefficient, expensive healthcare with a direct connection – either virtually or in-person – between patients and physicians. This direct connection enables Sesame to offer doctor visits, labs, imaging and prescription drugs at half the price. Founders include a Harvard PhD in health policy and economics; a former Goldman Sachs analyst; and entertainment executive and healthcare reformer David Goldhill, author of the legendary cover story in The Atlantic, "How American Health Care Killed My Father." Sesame …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

6 2 5 143
Foghorn Therapeutics Inc. Foghorn Therapeutics Inc.

Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 3 129
DTF medical DTF medical

NOUS AGISSONS POUR ACCOMPAGNER LA VIE Based in Saint Etienne (France) since 1951, DTF medical specializes in the design, manufacture and sale of top-quality, innovative medical devices. This family owned company, which have been managed by two founding families members for three generations, is recognized via the brands Kitett, Atomisor and Matelas DTF in France and abroad. Backed by powerful research capabilities, an enthusiastic and committed personnel, DTF medical serves the needs of patients and care professional alike. Its mission is to serve and assist them at every life stage. Breast feeding, Aerosothearpy & Nebulizing, Pressure Ulcer Prevention & Treatment, …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

2 2 1 64
AELIS FARMA AELIS FARMA

A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 2 4 27
Prime Roots Prime Roots

Prime Roots is making plant-based deli classics. Join our team & build a better food system! Prime Roots is celebrating the culture of meat by reimagining protein itself. Join our team & build a better food system from and for the planet.

Type: Startup Activities: foodtech Technologies: Synthetic Biology

2 2 0 46
BlueNalu BlueNalu

Cell-cultured seafood company, satisfying the global appetite for seafood in a fresh, sustainable and humane way. BlueNalu's mission is to be the global leader in cell-cultured seafood, providing consumers with great tasting, healthy, safe and trusted seafood products, that support the sustainability and diversity of our ocean. Consumers worldwide have become increasingly aware of the challenges that exist in our fishing and seafood industry. BlueNalu will disrupt the current industry practice, in which fish are farmed or wild-caught in our oceans and seas. Instead, we will produce real seafood products directly from fish cells, in a way that is healthy …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

7 2 3 59
Imagindairy Imagindairy

Dairy Done Differently Imagindairy, a Foodtech company, is addressing the industry bottleneck by integrating deep tech with system biology to develop a commercial and viable animal free protein-based dairy product

Type: SMB Activities: deeptech Technologies: Synthetic Biology

4 2 2 43
Plantible Foods Plantible Foods

We're hiring! Plantible Foods is a B2B food technology company with the goal to develop the most functional and applicable plant-based protein in the world using scalable and sustainable aqua-farming and extraction technologies

Type: SMB Activities: foodtech Technologies: Synthetic Biology

5 2 3 45
Asklepios BioPharmaceutical, Inc. (AskBio) Asklepios BioPharmaceutical, Inc. (AskBio)

Pioneering science to create transformative molecular medicines. Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10TM, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

5 2 1 467